fda not allowing compounded semaglutide is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified The End of Compounded Semaglutide:

In a placebo controlled ingredient level study, it improved the look of skin hydration and barrier comfort and a more even tone in as little as two weeks, including a measurable reduction in water loss through the skin (Mibelle Biochemistry, ingredient level data)

Forward operating environments often lack reliable refrigeration

AI-Based Fibrosis Assessment in MASH Drug Development. ScholasticaHQ , 2023, fmai.scholasticahq.com/article/121609-second-harmonic-generation-digital-pathology-with-artificial-intelligence-breakthroughs-in-studying-fibrosis-dynamics-and-treatment-response

Tip xc vi cc yu t, dn n s i mu, kh v nhanh chng nhn

The remaining 25 articles were included in the qualitative synthesis, and 16 in the quantitative synthesis (Figure 1)